NCT05192174View on ClinicalTrials.gov

Study of NIB101 in Participants With Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 24, 2022

Primary Completion Date

May 16, 2025

Study Completion Date

May 16, 2025

Conditions
Solid Tumor
Interventions
BIOLOGICAL

NIB101

NIB101

Trial Locations (2)

Unknown

National Cancer Center Hospital East, Kashiwa

National Cancer Center Hospital, Chuo Ku

Sponsors
All Listed Sponsors
lead

Noile-Immune Biotech, Inc

INDUSTRY